How many insider declarations has Sarraf Pasha filed?

Sarraf Pasha has filed 3 public insider declarations with SEC (Form 4).

What is Sarraf Pasha's role?

Sarraf Pasha's reported role is not specified by the regulator across the filings.

Which companies does Sarraf Pasha report trades for?

Sarraf Pasha reports trades for Cue Biopharma, Inc..

What is Sarraf Pasha's declared buy vs sell volume?

Across the available history, declared buys total 1k€ and disposals 0.

← Executives ★ Sign in to follow

SP

Sarraf Pasha

OFFICERM

·SEC (Form 4)

Cue Biopharma, Inc.

0

申报总数

0

公司

€1,111

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

T+90 胜率

0%

T+90 平均收益

-53.8%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

无可用的信号评分。

Discover the full record of transactions filed by Sarraf Pasha. Officer active across 1 company, notably Cue Biopharma, Inc.. In total, 3 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €1k. History available since 30 December 2025. The latest transaction was filed on 9 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Sarraf Pasha

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Cue Biopharma, Inc. (US)

申报3 总计

◆

Sarraf Pasha

Director高管2026年7月9日Cue Biopharma, Inc.

0SEC ↗

18,400 股0Common StockSEC:0002059447-26-000006:0

◆

Sarraf Pasha

Director高管2026年7月9日Cue Biopharma, Inc.

0SEC ↗

21,800 股0Common StockSEC:0002059447-26-000004:0

▲

Sarraf Pasha

Director高管2025年12月30日Cue Biopharma, Inc.

US$1,30823SEC ↗

4,229 股@ US$0.3094100.0% 占其流量Common StockSEC:0001193125-26-000900:0

标准退出：2026年3月30日 (T+90)

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

SP

Sarraf Pasha

OFFICERM

·SEC (Form 4)

Cue Biopharma, Inc.

0

申报总数

0

公司

€1,111

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

T+90 胜率

0%

T+90 平均收益

-53.8%

基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。

信号历史

无可用的信号评分。

Discover the full record of transactions filed by Sarraf Pasha. Officer active across 1 company, notably Cue Biopharma, Inc.. In total, 3 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €1k. History available since 30 December 2025. The latest transaction was filed on 9 July 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.